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Polysialic acid sustains cancer cell 
survival and migratory capacity in a 
hypoxic environment
Sara M. Elkashef1, Simon J. Allison2, Maria Sadiq1, Haneen A. Basheer1, 
Goreti Ribeiro Morais1, Paul M. Loadman1, Klaus Pors1 & Robert A. Falconer1
Polysialic acid (polySia) is a unique carbohydrate polymer expressed on the surface of NCAM (neuronal 
cell adhesion molecule) in a number of cancers where it modulates cell-cell and cell-matrix adhesion, 
migration, invasion and metastasis and is strongly associated with poor clinical prognosis. We have 
carried out the first investigation into the effect of polySia expression on the behaviour of cancer cells 
in hypoxia, a key source of chemoresistance in tumours. The role of polysialylation and associated 
tumour cell migration and cell adhesion were studied in hypoxia, along with effects on cell survival 
and the potential role of HIF-1. Our findings provide the first evidence that polySia expression 
sustains migratory capacity and is associated with tumour cell survival in hypoxia. Initial mechanistic 
studies indicate a potential role for HIF-1 in sustaining polySia-mediated migratory capacity, but 
not cell survival. These data add to the growing body of evidence pointing to a crucial role for the 
polysialyltransferases (polySTs) in neuroendocrine tumour progression and provide the first evidence to 
suggest that polySia is associated with an aggressive phenotype in tumour hypoxia. These results have 
significant potential implications for polyST inhibition as an anti-metastatic therapeutic strategy and 
for targeting hypoxic cancer cells.
Polysialic acid (polySia) is an α -2,8-glycosidically linked polymer of sialic acid, and a developmentally regulated 
post-translational modification of NCAM (neuronal cell adhesion molecule)1. Cancers of neuroendocrine-origin 
exhibit selective high level expression of polySia-NCAM as part of the tumour glycocalyx, a term used to 
describe the myriad of functionally-important carbohydrates that are to be found on the surface of cancer cells2. 
Tumours where polySia expression has been identified notably include neuroblastoma3,4, lung cancer5,6 and many 
others1,7–11. Crucially, whilst high levels are expressed during embryonic development, peripheral adult organs do 
not express polySia-NCAM. This means that the polysialyltransferase (polyST) enzymes (ST8SiaII and ST8SiaIV) 
responsible for polySia biosynthesis12 have received considerable interest as novel anti-metastatic drug targets, 
particularly ST8SiaII, which is thought to be the prominent enzyme in tumours1.
PolySia-NCAM expression strongly correlates with the migration and invasion of tumour cells13 and with 
aggressive, metastatic disease and poor clinical prognosis in the clinic1. Its detailed roles in tumour growth and 
dissemination continue to emerge, but involve disruption of homo- and heterophilic NCAM interactions, and 
in modulation of key intracellular signalling pathways, notably FGFR-1, ERK1/2, FAK and c-MET/ALK1,14,15. 
Furthermore, it has long been proposed that polySia-NCAM expression may protect the tumour cell from immu-
nosurveillance mechanisms, in a manner analogous to bacteria expressing polySia16 and that it is closely associ-
ated with tumour chemoresistance17.
The tumour microenvironment is intimately connected with the evolution of cancers and the limited suc-
cess of cancer treatments. Hypoxia, a condition of low oxygen tension occurring in poorly vascularised areas of 
tumours, has profound effects on cancer cell growth18,19, metastasis20,21, susceptibility to apoptosis22,23 and resist-
ance to radiotherapy and chemotherapy24,25. Within solid tumours, oxygen delivery to neoplastic and stromal 
cells in different regions of the tumour varies considerably due to the chaotic nature of the tumour vasculature 
and the diffusion limit of oxygen of just a few hundred micrometres. Oxygen gradients exist across the tumour 
with decreasing levels of oxygen as distance from a blood vessel increases. Whilst different levels of hypoxia are 
thus likely to exist in different parts of the tumour, in general, hypoxic cancer cells are associated with a more 
1Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, West Yorkshire BD7 1DP, U.K. 
2Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, U.K. 
Correspondence and requests for materials should be addressed to R.A.F. (email: r.a.falconer1@bradford.ac.uk)
received: 28 May 2016
Accepted: 15 August 2016
Published: 09 September 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:33026 | DOI: 10.1038/srep33026
aggressive, invasive phenotype26–28. The altered glycosylation of cancer cells appears to play a key role in this; 
promoting loss of cell-cell adhesion and cell migration29,30. However, how glycosylation changes under hypoxia 
and what effect, if any, this has on the behaviour of cancer cells, such as their growth, survival and invasive poten-
tial remain largely unexplored. Given the key role played by polySia in neuroendocrine tumour progression, we 
hypothesised that polySia may play a crucial role in tumour cell behaviour under hypoxic conditions.
Materials and Methods
Cell lines. Human neuroblastoma SH-SY5Y (ATCC® CRL 2266™ ) and DLD-1 colorectal adenocarcinoma 
(ATCC® CCL 221™ ) cell lines were obtained from the American Type Culture Collection (ATCC). Human 
neuroblastoma SH-SY5Y cells were maintained in MEM medium and nutrient mixture F-12 Ham (1:1), sup-
plemented with 10% foetal bovine serum, 1% sodium pyruvate and 1% glutamine. DLD-1 colorectal adeno-
carcinoma cell lines were maintained in RPMI media supplemented with 10% foetal bovine serum, 1% sodium 
pyruvate and 1% glutamine. C6-STX and C6-WT cells were obtained from the Fukuda group, Sanford-Burnham 
Prebys Medical Discovery Institute, La Jolla, CA, USA (for full details, see Suzuki et al.)31. Briefly, C6-STX glioma 
cells were prepared by transfecting wild-type C6 cells (C6-WT) with the pcDNA3-STX plasmid inserted with 
cDNA encoded full length human ST8SiaII (also known as STX)31. Both cell lines were maintained in minimum 
essential medium (MEM Alpha Eagle) with ultraglutamine I, deoxyribonucleoside and ribonucleosides supple-
mented with 10% foetal bovine serum. All cell lines were maintained in a humid atmosphere of 5% CO2 and 95% 
air at 37 °C.
For studies carried out under conditions of low oxygen tension (“hypoxic conditions”), all media used was 
incubated for at least 48 hours under hypoxic conditions (0.1% oxygen) before being added to the cells.
MTT cell viability assay. C6 glioma cells (5 × 103 cells/well) were seeded in 96-well plates. After overnight 
attachment, the cells were treated with different concentrations of cobalt chloride (Sigma–Aldrich) to induce 
pseudohypoxia. Following 24 h treatment, cells were washed and fresh media was added. Cells were incubated for 
another 72 hours and MTT (0.5 mg/ml) was then added followed by incubation for a further 4 hours. The MTT 
metabolic product (formazan) was dissolved in DMSO (200 μ L), and its absorbance was measured at 560 nm. Cell 
survival was calculated in relation to control (vehicle-treated) cells.
In vitro cell migration assay. Effects on tumour cell migration were analysed using a simple 2D scratch 
assay13,32. Cells were seeded into six-well plates at different concentrations (1 × 106 cells for SH-SY5Y, 0.5 × 106 
cells for C6 and 0.8 × 106 cells for DLD-1), and plates were then incubated overnight at 37 °C in a 5% CO2 humid-
ified atmosphere. Once a confluent monolayer had formed, a 200 μ l pipette tip was used to create a scratch 
wound. The monolayer was then washed with growth medium (1 ml) to remove floating cells and replaced with 
fresh medium (2 ml) containing only 2% FBS to limit cell proliferation. For experiments under hypoxia, the 
scratch was performed in a hypoxia station (Whitley H35 hypoxystation; Don Whitley, UK) at 0.1% O2 and 
hypoxia-equilibrated media was used. Images of the scratch at the start of the experiment were acquired using a 
Lumascope 500 microscope (Etaluma, USA) and reference points were marked to obtain the same field during 
the image acquisition after the incubation.
The plates were incubated in either normoxic (i.e. normal laboratory conditions) or hypoxic conditions for 
16, 24 and 41 hours for C6, SH-SY5Y and DLD-1 cells respectively. After incubation, plates were placed under the 
Lumascope 500 microscope, reference points were matched, the photographed region acquired at the first image 
was aligned and a second image was acquired.
The images acquired were analysed quantitatively by using Image J software. For each image, distances 
between one side of scratch and the other were measured at certain intervals (μ m). By comparing the images 
from time 0 to the last time point the % wound closure was calculated.
Chromatographic cell-based analysis of polySia expression. C6 cells were seeded at the density 
of 2 × 105 cells/well in a six-well plate and incubated at 37 °C in either hypoxic or normoxic conditions. After 
48 hours, cells were collected by trypsinisation followed by centrifugation for 5 minutes at 1000 rpm. Using 
routine mild acidic hydrolysis for polySia solubilisation33,34, cell pellets were treated with 100 μ L of 0.5% Igepal 
CA-630 (in distilled water) followed by incubation at 37 °C for 0.5–1 h and vortex mixing for 5 minutes. The insol-
uble material was removed by centrifugation and the supernatant was used for analysis. For Endo-N treatment 
for polySia solubilisation, cells were treated with Endo-N (3 μ g/ml) for 24 hours prior collecting the media. One 
well was used as negative control where no Endo-N was added.
For determination of polySia content, samples were hydrolysed in 0.1 M trifluoroacetic acid (TFA) for 2 h at 
80 °C. TFA was removed under vacuum and the resulting sialic acid residues were incubated with the DMB rea-
gent for 24 h at 4 °C as described previously13.
Mass spectrometric analysis of DMB-sialic acid. DMB-sialic acid was subjected to analysis by elec-
trospray UPLC-MS using an Acquity UPLC Waters system and a Quattro Premier XE (Waters corporation, 
USA) mass spectrometer and an Acquity UPLC BEH C18 column (2.1 × 100 mm). The mobile phases used were: 
ammonium formate (5 mM; mobile phase A) and methanol (mobile phase B), with a flow rate of 0.3 ml/min and 
isocratic method of 20% mobile phase B. The peaks and masses were integrated using Masslynx software. The 
source temperature was set to 120 °C. MRM transitions acquired at unit resolution in both the Q1 and Q3 quad-
rupoles to maximise specificity. Cone voltage (CV) was adjusted to 25 V while collision energy (CE) was adjusted 
to 20 V using positive ionisation mode. The transitions detected are summarised in Table 1.
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Cell-cell adhesion assay. C6 cells were incubated under hypoxic or normoxic conditions for 48 hours at 
37 °C. Matrigel© (200 μ l, 40 μ g/ml) (VWR, USA) solution was added to each well of a 24-well plate and incubated 
at 37 °C. After two hours, excess Matrigel was removed and the wells were washed twice with cold PBS. Blocking 
solution (DMEM media with %10 FBS, 500 μ l) was added to each well. The plates were then incubated at 37 °C. 
After 30 minutes the wells were washed once with cold PBS and fresh culture medium (200 μ l) was added and the 
plates were incubated at 37 °C.
2 × 104 cells in 100 μ l medium were added to the pre-coated 24-well plate. Culture medium (300 μ l) was added 
to one well to be used as a blank to calculate the background staining. The plates were incubated at 37 °C for 
30 minutes. Non-adherent cells were removed by inverting the plates on a plastic reservoir. Wells were washed 
two times with 300 μ l ice-cold PBS containing 1 mM CaCl2 and 1 mM MgCl2. Cells were fixed by adding ice-cold 
100% methanol (300 μ l). After 10 minutes, wells were washed with PBS three times and of 0.5% crystal violet 
solution, prepared in 20% ethanol (100 μ l), was added. Plates were placed on a shaker and incubated with crystal 
violet solution for 10 minutes at room temperature. Excess crystal violet solution was then removed. Crystal vio-
let was then recovered by adding 200 μ l of 100% methanol to each well. 100 μ l of the extracted crystal violet was 
transferred to 96-well plate. Absorbance of the samples was measured spectrophotometrically at a wavelength 
of 540 nm. The background absorbance of multi-well plates was also measured and subtracted from the 540 nm 
measurements.
Absorbance readings acquired for each sample were analysed quantitatively. Background absorbance of 
the multi-well plates was subtracted and the % cell adhesion relative to C6-WT cells was calculated (% adhe-
sion = mean absorbance of the C6-WT cells /mean absorbance of C6-STX cells in the same condition × 100). 
Three independent experiments were carried out, each comprising 4 technical replicates.
Trypan blue exclusion assay for cell viability. C6 cells were seeded in T75 flasks with seeding density 
of 2.5 × 104 cells/flask, with one flask per treatment incubated in normoxic conditions and the other in hypoxic 
(0.1% O2) conditions for 96 hours. 0.4% solution of trypan blue was prepared in PBS solution (pH 7.2) and 0.1 mL 
of trypan blue stock solution was added to 1 mL of trypsinised cells. Each haemocytometer chamber was loaded 
with 10 μ l of the solution and examined immediately under a microscope at low magnification. The number of 
trypan blue-stained cells and the number of total cells was counted. The % trypan blue-stained cells was calculated 
as follows: % dead cells = (Average number of trypan blue-stained cells count ÷ average total cell count) × 100.% 
cell viability was also calculated as follows: % Viable cells = [1.00 – (Number of blue cells ÷ Number of total 
cells)] × 100.
Flow cytometry (Annexin V apoptosis detection assay). C6 cells were seeded (8 × 105 cells) in T75 
flasks under normoxic or hypoxic (0.1% O2) conditions at 37 °C. After incubation for 96 h, media was collected 
and cells were trypsinised. Trypsinised cells, along with the collected media, were then centrifuged at 1000 g for 
5 minutes. After centrifugation, media was discarded and cell pellets were re-suspended in HEPES buffer (1 ml) 
as provided with the Annexin V_FLUOS staining kit (Roche) in accordance with the manufacturer’s instructions. 
Cells were further centrifuged (1500 g, 5 minutes) and pellets were re-suspended in 100 μ l HEPES buffer con-
taining Propidium iodide and Annexin V as previously described35. After 15 minutes, 0.5 ml of Annexin-binding 
buffer was added and cell samples were analysed by flow cytometry.
Western blot analysis. For CoCl2 treatment, C6-STX and C6-WT cells were seeded at a density of 2 × 105 
cells/well in a six-well plate and incubated for 24 hours at 37 °C in a 5% CO2 humidified atmosphere to allow cells 
to adhere. After 24 hours, medium was removed and fresh medium containing different concentrations of CoCl2 
was added. Two wells were used as a control where no CoCl2 was added. After 16 hours cells were collected.
Samples were resolved on 12% polyacrylamide gels and blotted onto PVDF membranes (Amersham). 
Non-specific antibody binding was blocked via incubation with skimmed milk (0.05 g/ml) and the blot 
was probed with rat anti-HIF-1α antibody (R&D systems, UK) (1:100 dilution) or rat anti-LDH-A antibody 
(Abcam, UK) (1:500 dilution) overnight at 4 °C. Antibody reactivity was detected by horseradish peroxidase 
(HRP)-conjugated antibody and chemiluminescence using ECL-Plus (Amersham).
RT-PCR analysis. RNA purification and quantification. C6 were incubated in normoxic or hypoxic condi-
tions for 48 h, after which RNA was extracted using the RNeasy Mini Kit (Qiagen, UK) according to the manufac-
turer’s instructions. The concentration and quality of the eluted RNA were determined by measuring absorbance 
at 260 nm and 280 nm using a NanodropTM2000 (Thermo Fisher Scientific) spectrophotometer and determining 
the 260/280 ratio.
2000 ng of total RNA was reverse transcribed into single-stranded cDNA using the High Capacity cDNA 
Reverse Transcription Kit (Life technologies) according to manufacturer’s handbook. Once the reaction finished, 
samples were stored at − 20 °C.
Transition Molecular weight (MW) Charge Z Parent ion (m/z) Daughter ion (m/z) CV (V) CE (eV) Dwell time (sec)
1 425.4 + 1 426 229.23 25 20 0.2
2 425.4 + 1 426 313.02 25 20 0.2
Table 1.  Transition data for mass spectrometric analysis of DMB-sialic acid.
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Real-time quantitative PCR. qPCR was carried out using the TaqMan Universal PCR Master Mix (Applied 
Biosystems). The PCR reaction consisted of 12.5 μ l of 2X master mix, 1.25 μ l of 20X TaqMan Gene Expression 
Assay Mix, and 11.25 μ l cDNA diluted in dH2O. The cDNA samples were diluted 1:5 and 2 μ l of diluted cDNA 
was used per reaction. A 96-well MicroAmp Optical plate (Applied Biosystems) was used and all reactions were 
performed in triplicate. The validated Taqman primers (Applied Biosystems) utilised are listed in Table 2. qPCR 
reactions were performed using a AB7500 Real time PCR system (Applied Biosystems). The fold-change in gene 
expression was determined using the 2-ddCT method36.
Statistics. A minimum of three independent biological experiments were performed for all studies. Statistical 
analyses were performed using Excel software. Differences between two groups were evaluated with Student’s t 
test (Two tailed).
Results and Discussion
Evaluation of polySia expression in C6-STX cells under hypoxic conditions. Cells were ini-
tially evaluated to assess the effect of hypoxia on polySia expression. The isogenic C6 glioma cells served as an 
ideal model in this regard. First reported by the Fukuda group31, C6-STX cells have been engineered to express 
ST8SiaII and thus express polysialylated NCAM (polySia-NCAM)13. The merits of these cells as a model for pol-
ySia-expressing cancer cells are well established13,31,37. C6-STX cells migrate and invade significantly faster than 
C6-WT (wild type) cells in vitro13,31 and in vivo31. Our own experiments have additionally confirmed that levels of 
polySia expression in C6-STX cells are similar to those observed in naturally expressing cell lines (e.g. SH-SY5Y, 
data not shown). C6-STX and C6-WT cells are otherwise genetically identical (expressing NCAM, the acceptor 
for polySia), only differing in the expression of ST8SiaII and associated polySia31. We were thus able to reasonably 
attribute any effects observed in the subsequent experiments to the presence of polySia.
C6-STX cells were incubated at 37 °C in either 0.1% oxygen, 5% carbon dioxide and 95% nitrogen (hypoxia) or 
5% carbon dioxide and 95% air (normoxia). After 48 h, cells were harvested and polySia expression was quantified 
using a cell-based chromatographic assay (see Methods).
Interestingly, a comparison of the polySia expression of C6-STX cells under hypoxia and normoxia revealed a 
marked difference. C6-STX cells exhibited a significant reduction in polySia expression of polySia under hypoxia 
conditions (61.8 ± 4.8% of that measured under normoxia, P = 0.01, Fig. 1). The use of C6-WT cells as a negative 
control confirmed a lack of polySia expression under both conditions (data not shown) and validated the assay 
given the isogenic nature of the cells. Cell-based quantification of cell-surface polySia was carried out using both 
endoneuraminidase-N (Endo-N, an enzyme that selectively cleaves polySia) and mild acidic hydrolysis for the 
removal of polySia from the cell surface, two techniques routinely available to us in our laboratory. Similar results 
were obtained from both experiments, giving confidence in the result obtained (SD ± 10%).
These data show that steady-state levels of exogenously expressed polySia are reduced in C6-STX cells under 
hypoxic conditions. These findings are exciting and represent the first such evidence that hypoxia affects polySia 
expression in tumour cells. That said, these results are consistent with previous studies that have more broadly 
suggested that acute hypoxia produces a degree of glycocalyx degradation38.
Effect of hypoxia on polySia-mediated tumour cell migration. PolySia has been shown to play a key 
role in tumour cell migration. Generally speaking, there are many reports demonstrating that hypoxia modulates 
cancer cell migration39,40. Given our determination that polySia levels were reduced under hypoxic conditions, 
implications for tumour cell migration were investigated.
The effect of polySia expression on tumour cell migration under hypoxic conditions was once again ana-
lysed using the C6 glioma cell line pair: C6-STX (polySia+/NCAM+) and C6-WT (polySia−/NCAM+). We, along 
with our collaborators before us, have previously demonstrated that C6-STX cells migrate significantly faster 
than C6-WT cells in normoxia13,31. We additionally evaluated naturally polySia-expressing neuroblastoma cell 
line SH-SY5Y (polySia+/NCAM+), and utilised DLD-1 colorectal cancer cells as a negative control (polySia−/
NCAM−). Migration was evaluated using a simple scratch assay32, routinely used in our laboratory. For the two 
polySia-expressing cell lines (C6-STX and SH-SY5Y), no difference in cell migration was observed between 
the hypoxic and normoxic conditions. This is intriguing given our finding that polySia expression is reduced in 
C6-STX cells under hypoxia. Interestingly, the control cells (C6-WT and DLD-1), which do not express polySia, 
showed a significant and marked reduction in cell migration under hypoxia (Fig. 2a,b).
Given these results, we hypothesised that a polyST inhibitor would reduce polySia expression further and thus 
may reduce migration of polySia-expressing cells under hypoxia. We have previously demonstrated that polyST 
inhibitor ICT-3176 reduces tumour cell migration in polySia-expressing cells (including C6-STX and SH-SY5Y 
cells) with high selectivity41. C6-STX cells were thus treated with ICT-3176 (250 μ M) under hypoxic conditions. 
Cell migration was compared with non-treated cells. Treatment of the cells with ICT-3176 resulted in significant 
inhibition of C6-STX cell migration (22.4 ± 2.5%, Fig. 2c,d) in hypoxia. As expected, ICT-3176 treatment showed 
no effect on C6-WT cells.
Target gene (C6 cell lines) TaqMan gene expression assay
GLUT1 Rn01402419_g1
HK2 Rn00562457_m1
LDH-A Rn00820751_g1
Table 2.  Validated Taqman primers utilised in PCR experiments.
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Taken together, these results demonstrate that the polySia-expressing tumour cells evaluated under hypoxia 
are able to maintain the migratory capacity observed in normoxia, and this is despite the significant reduction in 
polySia expression levels noted earlier. Furthermore, polyST inhibition results in reduced migration in hypoxia, 
as it does in normoxia.
Effect of hypoxia on polySia-mediated cancer cell-matrix adhesion. It was previously reported that 
polySia modulates cancer cell adhesion through modulation of NCAM-NCAM interactions and NCAM interac-
tion with other molecules in addition to exerting a repulsive force created by the negative charge on the polySia 
chains. Furthermore, evidence has been reported suggesting that polySia and hypoxia modulate the c-MET sig-
nalling pathway, which has a significant role on cancer cell adhesion42.
In order to investigate the effect of hypoxia on polySia-mediated tumour cell-matrix adhesion, an assay 
was performed with C6-STX and C6-WT cells after 48 hour growth in either normoxic or hypoxic conditions. 
C6-STX cells were less able to adhere to Matrigel© than C6-WT cells, irrespective of oxygen conditions. Adhesion 
capacity in polySia-expressing C6-STX cells was approximately 15% less than that observed in control C6-WT 
cells. There was no difference, however, in cell adhesiveness between normoxic and hypoxic conditions for either 
C6-STX or C6-WT cells (P = 0.9 for C6-STX cell adhesion in hypoxia compared to normoxia; P = 0.3 for C6-WT 
adhesion in hypoxia compared to normoxia, see Supplementary data S1).
These results suggest that unlike migration, hypoxia does not appear to have any significant effect on 
polySia-mediated cell-matrix adhesion, at least to Matrigel in this case. The lack of a difference between adhesion 
observed in hypoxia and normoxia is perhaps surprising given the lower quantity of polySia expressed by C6-STX 
cells under hypoxic conditions. It may be that polySia modulates cell adhesion by interacting with different signal-
ling pathways under hypoxic conditions, such as c-MET which is over expressed in hypoxic conditions43,44. This 
is interesting and certainly worthy of further exploration.
Effect of polySia expression on cancer cell survival in hypoxia. We next considered whether polySia 
plays any role in cell survival under hypoxic conditions. In order to determine this, C6-STX and C6-WT cells were 
subjected to hypoxia for 96 h while control cells were incubated for the same duration under normoxic condi-
tions. After 96 h, cells were examined under the microscope and were subsequently collected. Viable and dead cell 
counts were determined using trypan blue staining. Interestingly, polySia-expressing cells were associated with 
significantly higher cancer cell viability under hypoxic conditions compared to controls (Fig. 3a). The trypan blue 
exclusion assay revealed that after 96 h under hypoxia, C6-WT control cells demonstrated significantly reduced 
viability, as evidenced by a greater number of trypan blue-stained cells (Fig. 3b). C6-WT cells demonstrated cell 
viability of 80% (i.e. 19.7 ± 3.8% trypan blue-stained cells, Fig. 3b) compared to C6-STX polySia-expressing cells 
with cell viability of 98% (i.e. 1.6 ± 0.6% trypan-blue stained cells, Fig. 3b).
In order to further analyse this reduction in cell survival observed under hypoxia and potential mechanisms of 
increased cell death in the C6-WT cells, levels of apoptosis in hypoxia-cultured C6-STX and C6-WT cells were deter-
mined. As shown in Fig. 3c, the apoptotic fraction of C6-WT cells was significantly higher than that of C6-STX cells 
under hypoxic conditions (18.5% apoptotic cells in C6-WT compared to 4.9% apoptotic cells in C6-STX, i.e. 73.5% 
less apoptosis in C6-STX cells, Fig. 3d, Table 3), while no significant difference was observed in normoxia. These 
results strongly suggest that polySia expression plays a key role in enhancing C6 glioma cell survival in hypoxia.
Figure 1. Effect of hypoxia (48 hours, 0.1% O2) on polySia expression in C6-STX cells. (a) Mild acidic 
hydrolysis combined with UPLC/MS/MS analysis used to detect polySia in C6-STX cells under normoxia 
(upper trace) and hypoxia (lower trace, after 48 hours). Y-axis represents % abundance of polySia, x-axis 
represents time. (b) Elution standard for standard DMB-labelled sialic acid (upper trace) and negative control 
sample where no Endo-N was added as described in the material and methods section (lower trace).  
(c) Quantification of the mean polySia levels as determined by HPLC. (**P ≤ 0.01).
www.nature.com/scientificreports/
6Scientific RepoRts | 6:33026 | DOI: 10.1038/srep33026
For comparison, we additionally performed this experiment using SH-SY5Y cells, which naturally express 
polySia. The levels of apoptosis in SH-SY5Y cells cultured in hypoxia and normoxia were similarly compared. No 
significant difference in the percentage of viable cells cultured in hypoxia or normoxia was identified, mirroring 
the results obtained using C6-STX cells (Supplementary data S2).
Investigating a potential role of hypoxia-inducible factor-1 (HIF-1) in the altered behaviour 
of polySia-expressing tumour cells under hypoxic conditions. A critical mediator of the hypoxic 
response is the transcription factor hypoxia-inducible factor 1 (HIF-1) that upregulates expression of proteins 
that promote angiogenesis, anaerobic metabolism, metastasis and many other survival pathways45. Glucose 
metabolism is upregulated by many cancer cells under hypoxia, generating lactate through the enzyme lactate 
dehydrogenase A (LDH-A)46, an established HIF-1a target gene47,48. HIF-1 activity in tumours depends on the 
Figure 2. Effect of polySia on the migration of tumour cells under hypoxic conditions. (a) Representative 
images of the migration of SH-SY5Y, C6-STX cells (expressing polySia), and control cell lines C6-WT and DLD-1 
using time-lapse microscopy under hypoxia, showing the wound size immediately and 16, 24 and 41 hours after 
scratching; (b) Graph representing the quantification of wound closure calculated by measuring the reduction 
of wound area over time, using Image J software. Wound closure under hypoxia is calculated as a percentage of 
wound closure under normoxia for each cell line; (c) Effect of ICT-3176 treatment on C6-STX cell migration under 
hypoxia; (d) Representative images of the migration of C6-STX cells after treatment with ICT-3176 compared to 
control untreated cells under hypoxia. T1 = 16 h (C6-STX, C6-WT); 24 h (SH-SY5Y); 41 h (DLD-1). (**P ≤ 0.01).
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availability of the HIF-1α subunit, the levels of which increase under hypoxic conditions and through the activa-
tion of oncogenes and/or inactivation of tumour suppressor genes49,50.
In order to investigate whether HIF-1α plays any role in the altered polySia-mediated cancer cell behaviour 
observed under hypoxic conditions, we utilised an established experimental tool to investigate HIF-1 depend-
ency of hypoxia-induced phenomena, namely cobalt chloride (CoCl2). CoCl2 administration under normoxia 
is thus a simple means by which to mimic the HIF-1-dependent processes that normally occur under hypoxia. 
CoCl2 stabilises HIF-1α by blocking post-translational modification by prolyl hydroxylase51,52. Whereas CoCl2 
Figure 3. Effect of polySia expression on the survival of cancer cells in hypoxia. (a) Morphological change 
in C6-STX and C6-WT cells after incubation under hypoxic or normoxic conditions for 96 h; (b) Trypan blue 
exclusion assay, showing the effect of hypoxia on the viability of C6 cells. The graph represents the mean of three 
independent experiments; (c) Flow cytometry analysis of C6-STX and C6-WT cells apoptosis under hypoxic 
and normoxic conditions after 96 h. The x-axis shows levels of annexin V cellular staining whereas levels of 
propidium iodide staining are shown on the y-axis; lower left quadrant of dot plots 1–4: live cells (annexin 
V-negative, propidium iodide-negative); lower right quadrant: early apoptotic cells (annexin V-positive, 
propidium iodide-negative); upper right quadrant: late apoptotic or necrotic cells (annexin V-positive, 
propidium iodide-positive); upper left quadrant: mechanically damaged cells (annexin V-negative, propidium 
iodide-positive). C1 represents C6-WT in normoxia, C2 represents C6-WT cells in hypoxia, C3 represents C6-
STX cells in normoxia, C4 represents C6-STX cells in hypoxia; (d) Percentage of annexin V staining of cell lines 
under each condition. (**P ≤ 0.01; ***P ≤ 0.001).
Cell line and conditions
Apoptotic cells (%)
Viable cells (%)Late apoptotic (necrotic) Early apoptotic
C6-WT (Normoxia) 0.64 ± 0.19 1.75 ± 1.24 96.22 ± 1.14
C6-WT (Hypoxia) 10.6 ± 0.60 7.89 ± 1.24 79.03 ± 1.50
C6-STX (Normoxia) 0.53 ± 0.13 1.33 ± 0.19 97.48 ± 0.37
C6-STX (Hypoxia) 2.16 ± 0.29 2.75 ± 0.46 94.45 ± 0.04
Table 3.  Summary percentages of annexin V-stained C6 cells under normoxia and hypoxia.
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lacks exquisite selectivity for HIF-1α , it is routinely used in this context as a tool prior to more complex experi-
ments53,54. In the next few experiments, the effect of HIF-1α induction using CoCl2 on the key polySia-induced 
behavioural changes of cancer cells under hypoxia were examined.
Determination of CoCl2 cytotoxicity. In order to determine the most suitable CoCl2 concentrations for 
studying the effect of HIF1α induction on both migration and survival of C6 cell lines, an MTT viability assay 
was performed.
In this experiment, the viability of C6-STX and C6-WT cells was examined after incubation with different 
concentrations of CoCl2 for 24 hours to determine IC50 values. These were determined to be 258 ± 10 μ M for 
C6-STX cells and 289 ± 12 μ M and C6-WT cells (Fig. 4a). For the migration assay, a concentration of CoCl2 
that did not cause a significant reduction in the viability of either cell line was used, i.e. 100 μ M. For studying the 
ability of cells to survive under stress conditions, 200 μ M of CoCl2 was utilised, a concentration causing approxi-
mately 20% loss in viability of cell population.
In the absence of being able to reliably detect changes in HIF-1α expression directly, we focused instead on 
induction of LDH-A expression to confirm effects of CoCl2, which are well established. Whilst important in 
itself, LDH-A induction by CoCl2 has additionally been routinely utilised by others as an indirect indicative 
marker of transcriptionally active and functional HIF-1a expression, given its strong correlation with HIF-1α 
expression55,56. Expression of LDH-A in both C6-STX and C6-WT CoCl2-treated cells was significantly higher 
than control untreated cells. On this basis, we could additionally assume induction of HIF-1α expression and 
pseudohypoxia (Supplementary data S4).
Effect of CoCl2 on polySia-mediated tumour cell migration. In order to investigate whether the effect 
of polySia expression on enhancing migration of cancer cells under hypoxic conditions is HIF-1α -related, the 
migration of C6-STX and C6-WT cells was examined following treatment with 100 μ M CoCl2 (a non-toxic con-
centration, as determined above). Both C6-STX and C6-WT cells exhibited a significant reduction in tumour cell 
migration following CoCl2 treatment (Supplementary data S3). However, CoCl2 had a greater effect on C6-WT 
cells than C6-STX cells (35 ± 15% greater migration in C6-STX cells compared with C6-WT cells, P = 0.02, 
Fig. 4b). When considered in conjunction with the results obtained under hypoxia (Fig. 2a), this suggests a link 
between polySia-mediated migration of tumour cells under hypoxic conditions and LDH-A induction, with 
implications for HIF-1α .
Effect of CoCl2 on polySia-expressing cancer cell survival. Following our observation the 
polySia-expressing tumour cells exhibit enhanced cell survival under hypoxia, we evaluated the effect of CoCl2 
on cell survival. Percentage cell survival of C6-STX and C6-WT cells was examined after incubation with CoCl2 
(200 μ M; a concentration selected to study the ability of cells to survive under stress conditions) using the trypan 
blue exclusion assay. In contrast to the results obtained under hypoxia, no significant difference in cell survival 
was observed between C6-STX and C6-WT cells (P = 0.26, Supplementary data S5). This suggests that the 
enhancement of cell survival induced by polySia expression under hypoxic conditions may not be correlated to 
HIF-1α upregulation.
Differential expression of selected HIF-1α induced genes in C6-STX versus C6-WT cells under hypoxia. 
Possible cross-talk between polySia and glucose transporters has been previously suggested: 
N-Acetyl-D-mannosamine (ManNAc) and N-acetyl-D-glucosamine (GlcNAc) are the essential precursors of 
N-acetylneuraminic acid (NeuAc), the precursor monomer of polySia. Studies on the specificity of the ManNAc 
Figure 4. Effect of CoCl2 treatment on C6 cell lines. (a) Determination of IC50 of CoCl2 in C6-STX and 
C6-WT cell lines; (b) Quantification of migration of C6-STX and C6-WT cells after treatment with CoCl2, 
calculated by measuring the reduction of wound area over time using Image J software. The percentage of 
C6-WT wound closure after CoCl2 treatment is calculated as a percentage of the C6-STX wound closure. 
(*P ≤ 0.05).
www.nature.com/scientificreports/
9Scientific RepoRts | 6:33026 | DOI: 10.1038/srep33026
transport system have revealed that addition to the uptake mixture of glucose, fructose, mannose, glucosamine, 
mannosamine and GlcNAc (5 mM), but not other sugars, caused a marked inhibition in ManNAc transport 
(70, 60, 70, 60, 65 and 85%, respectively)57,58. Although this effect was observed in E. coli, given the link between 
hypoxia and increased glucose metabolism in cancer cells, this raised the question of possible cross-talk between 
polySia and these processes. In initial studies, we selected three key glucose metabolism regulators, namely glu-
cose transporter 1 (GLUT-1), hexokinase 2 (HK-2) and the aforementioned LDH-A55 for evaluation59–61. The 
change in expression of these genes was measured under hypoxia and normalised to expression under normoxia.
Gene analysis of the C6 isogenic cells revealed a significant increase in LDH-A gene expression in C6-STX 
cells under hypoxic conditions as compared to WT cells. This is a significant finding, suggesting a possible role 
for LDH-A in polySia-mediated changes in cancer cell behaviour in hypoxia (Fig. 5). LDH-A has previously been 
reported to promote cancer cell survival in multiple cancer cell lines35,46,62, and has also been shown to promote 
cancer cell migration under hypoxic conditions63.
Conclusion
The role of polySia in neuroendocrine tumours in tumour cell growth, dissemination and metastasis has now 
been widely reported. Whilst polySia expression has previously been proposed to be associated with chemore-
sistance, the significance of polySia expression in a hypoxic environment has not been studied. We have shown 
that while hypoxia leads to a reduction in polySia expression, this is strongly associated with increased cell sur-
vival, and sustains a migratory capacity. Initial mechanistic studies indicate a potential role for HIF-1 in sustain-
ing polySia-mediated migratory capacity, but not cell survival. Furthermore, our study additionally provides the 
first evidence of a role for LDH-A, a key regulator of glucose metabolism under hypoxia in cancer cells, in these 
processes.
This study paves the way for more detailed studies in a broader array of neuroendocrine cancer cell lines, and 
invites further investigations using more complex in vitro models (e.g. 3D spheroids) and ultimately in vivo. Our 
ability to modulate polySia expression using small molecule polyST inhibitor ICT-3176, in conjunction with our 
striking finding that cells engineered to express polySia exhibit significantly enhanced survival in a hypoxic envi-
ronment, raises exciting therapeutic implications for the targeting of hypoxic cells and for future anti-metastatic 
and combination therapies.
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